Stocks finished mixed again on Thursday in another quiet session. I checked the calendar, because the action feels eerily like a holiday reprieve. Where is everyone?Or maybe like a calm before a storm given threatening data on nascent deflation and a rollover in corporate earnings. I know it’s almost forbidden to say this out loud with sentiment so bubbly — […]
View photo.By and large, short interest among the leading biotechs and emerging pharmaceuticals reversed course and rose again between the January 30 and February 13 settlement dates.Leading that trend were Amgen, Inc. (NASDAQ: AMGN), Juno Therapeutics Inc (NASDAQ: JUNO) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX).Below we take a quick look at how these three stocks have fared recently and what […]
View original article:
Heavy News Day For Several Biotech Stocks
[…]
View photo.Biotechnology ETFs have leapt out of the gate in 2015 with another strong spurt of momentum that has catapulted them to the top of sector rankings. The unequivocal asset leader in this category is the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB), which has more than $8 billion under management.IBB has gained more than 12 percent so far this […]
In a report published Tuesday, JMP Securities named three biotech stocks it is watching: Acceleron Pharma Inc (NASDAQ: XLRN), Cardiovascular Systems Inc (NASDAQ: CSII) and Karyopharm Therapeutics Inc (NASDAQ: KPTI).Acceleron’s (Market Outperform, $52 price target) early stage clinical results at ASCO Genitourinary(GU) 2015 “support a positive outlook for maturing PFS results while providing encouragement for ongoing later stage development.”According to analyst Michael […]
Fits and starts in developing a revolutionary new inhaled insulin have meant that Al Mann’s MannKind has had more than its fair share of pops and drops over the past few years. MannKind won FDA approval for Afrezza last summer and announced its commercial launch earlier this month . The news has investors wondering if now is a good time […]
Source: Celgene CorporationIt’s been proven time and time again that investing for the long haul outperforms short-term trading, but biotechnology stock investors must also realize that the industry moves so quickly that only the best-of-breed players ought to be stashed away for the long term. For that reason, while I’m happy to own a few speculative biotech stocks here and […]
The fact that biotech stocks can trade up or down significantly based on news from clinical research trials ensures there is no shortage of pop-and-drop stories in this business. The industry’s volatility might scare off many investors, but for those willing to accept the risk, here are three tiny biotech stocks that could make big moves thanks to the release […]
…and its gets right to the point.. There are a lot of interesting set ups but I cut right to the chase we some great new and old set ups. The market will have to be monitored just because the possibility of some selling into any more news concerning Greece.be sure to watch the Futures overnight to get the first […]
By Profit Scanner for InvestorPlace MediaHealthcare has been far and away the best sector of 2015 so far — and biotech stocks are no exception.The iShares Nasdaq Biotechnology Index (ETF) (IBB) is up 9.4% in just the year-to-date; that’s about twice the return of the Nasdaq as a whole, and four-and-a-half times more than the S&P 500. And analysts at […]
